V itamin D is a fat-soluble vitamin found in the human diet and derived from dermal synthesis. 25 Its primary clinical function in human health is to support calcium homeostasis and bone metabolism. 23 Recognition of its pleiotropic effects in modulating immune and other cellar functions has increasingly been the central topic of an expanding body of literature.
V itamin D is a fat-soluble vitamin found in the human diet and derived from dermal synthesis. 25 Its primary clinical function in human health is to support calcium homeostasis and bone metabolism. 23 Recognition of its pleiotropic effects in modulating immune and other cellar functions has increasingly been the central topic of an expanding body of literature. 11 Vitamin D deficiency, or hypovitaminosis D, a prevalent problem in the general population, is associated with a higher mortality rate and poorer outcomes in critically ill populations. 30 The majority of studies performed have concerned the association of vitamin D levels and various critical and chronic illnesses, and much of the focus has been on generalized intensive care populations. Because the results of recent studies indicate that vitamin D might have neuroprotective attributes, 14, 27 links between hypovitaminosis D and critically ill patients with a neurological condition might necessitate altering treatment plans to improve outcomes in this population.
The results of a recent study that focused on the influence of hypovitaminosis D on the in-hospital mortality rate in a specialized neurocritical care unit (NCCU) suggest an association between vitamin D deficiency on admission and worse outcomes within this unique population. 8 Although the results of several studies also suggest that the effects of hypovitaminosis D on patient outcome extend beyond the hospitalization itself, 3 ,12 a paucity of data on the relationship between vitamin D status on ad-mission and postdischarge outcomes in neurocritical care patients exists. We prospectively studied the association between hypovitaminosis D on admission and 3-month postdischarge outcome of patients in a quaternary NCCU.
Methods

Study Population
After receiving approval from the University of Utah Institutional Review Board, which included a waiver of informed consent, data on 25-hydroxy vitamin D levels and other patient variables were gathered prospectively using a combination of clinical examination, review of radiological films, and evaluation of medical records. Each patient admitted to the NCCU (latitude 40.7717° north) between September 1, 2015, and February 29, 2016 , was eligible for enrollment in the study. Patients routinely undergo serum vitamin D (25-hydroxy vitamin D) evaluation. Patients were excluded if they were younger than 18 years at the time of admission, admitted under a service other than neurosurgery or neurology because of hospital intensive care bed needs, or unable to undergo vitamin D testing within 24 hours of admission to the NCCU. Patients who did not return to the clinic for evaluation 3 months after discharge were also excluded, because Glasgow Outcome Scale (GOS) scores in these patients could not be calculated without clinical follow-up. Patients who were readmitted to the NCCU before discharge were not dually enrolled.
Data Collection
Baseline demographic information, including age, sex, body mass index (BMI), and race/ethnicity, was obtained when available. Patient insurance type was recorded as private, Medicaid/self-pay, or Medicare. Medicaid is the US program designed to provide health insurance to people with low income, although eligibility requirements for coverage vary according to state. Medicare is the US program designed to provide health insurance for elderly people (defined as those aged 65 years or older), people with various disabilities, and those with certain medical conditions, such as end-stage renal disease or amyotrophic lateral sclerosis (https://www.medicare.gov). Each patient was assessed also for the presence of hypertension and diabetes and active use of tobacco, alcohol, and illicit drugs. Admission information for each patient, including whether surgical intervention was performed immediately before or during the NCCU admission and whether the admission was elective or emergent, was recorded. Patients considered to have been electively admitted include those who were scheduled for NCCU admission > 1 week before arrival in the NCCU, including those admitted for a prearranged cranial or spine procedure or planned diagnostic testing. Each admission diagnosis was placed into 1 of 4 categories: postoperative care, stroke (hemorrhagic or ischemic), trauma, or other. The 3 most common diagnoses under each category were craniotomy for resection of tumor, transsphenoidal resection of pituitary tumor, and endovascular treatment of unruptured intracerebral aneurysm (postoperative); traumatic subarachnoid hemorrhage, traumatic acute subdural hematoma, and traumatic cerebral contusions (trauma); ischemic stroke, hypertensive intraparenchymal hemorrhage, and aneurysmal subarachnoid hemorrhage (stroke); and status epilepticus, chronic subdural hematoma, and encephalopathy (other). Preadmission vitamin D supplementation, defined as daily supplemental intake > 500 U, was also recorded. Patients who were taking vitamin D supplementation before hospitalization were not continued on supplementation as inpatients, although those who were found to be deficient in vitamin D (< 20 ng/ml) were treated using 50,000 U of vitamin D 2 (ergocalciferol) administered orally or via feeding tube weekly, per hospital protocol.
To aid in controlling for illness severity, we calculated a Simplified Acute Physiology Score (SAPS II) for each patient. This score is an assessment of 17 physiological, demographic, and hospitalization-specific factors derived from an international sample of patients and validated as an indicator of risk of death for each patient during hospitalization. 15 The SAPS II has been shown to be associated with death in patient populations similar to that used in our study, 9, 19, 20, 28 21 Because of the association between renal disease and vitamin D deficiency, likely a result of the important role the kidneys play in vitamin D homeostasis, 1 each patient had a glomerular filtration rate calculated based on serum creatinine level measured within 24 hours of admission. 16 For instances in which more than 1 laboratory value was obtained, the value measured closest to the time of NCCU admission was used. The phosphate level was missing for 6 patients, and the median phosphate value (3.3 mg/dl) was substituted in all analyses for these patients.
The primary outcome for this study was the patient's 3-month GOS score as assessed during follow-up visits in the neurosurgery or neurology clinic (Fig. 1) . A score of 1 corresponds to death, 2 to a persistent vegetative state (unable to interact with the environment and unresponsive), 3 to severe disability (able to follow simple commands but unable to perform acts of daily living to the point of living independently), 4 to moderate disability (able to live independently but unable to return to work or school without special assistance), and 5 to low disability (minimal neurological or psychological deficit). 13 For this study, GOS scores were dichotomized into a score of 1-3 or 4-5. No formal blinding of those who assessed the GOS scores and vitamin D levels was performed. Secondary outcome measures included ventilator duration, NCCU length of stay, and hospital length of stay. Any development of urinary tract infection, pneumonia, or sepsis during the hospital stay was also recorded. In all cases, infection was defined as culture-positive evidence of infection that required treatment with antibiotic therapy.
Statistical Analysis
Continuous variables in all cases were analyzed using the Student t-test, and categorical variables were analyzed using c 2 analysis. Univariate analysis was performed for vitamin D status after dichotomization into the vitamin D-deficient (25-hydroxy vitamin D level ≤ 20 ng/ml) or vitamin D-sufficient (25-hydroxy vitamin D level > 20 ng/ml) group according to previously published cutoffs.
18,26 A separate univariate analysis using a cutoff of ≤ 12 ng/ml was performed to evaluate the effects of severe vitamin D deficiency, again according to previously published cutoffs. 2 Univariate analysis was performed also on 3-month GOS scores after dichotomization into scores of 1-3 or 4-5. Variables with a p value of < 0.2 in univariate analysis of GOS scores were included in a forward, stepwise, binomial logistic regression model with an entry cutoff of 0.05 and a removal cutoff of 0.10. Age was not included in our multivariable model, despite having a p value of < 0.2 in univariate analysis, because it is a component of the SAPS II. Mean values are presented ± SD.
Results
Of 888 unique admissions to the NCCU during the study period, 497 met criteria for inclusion. Of these patients, 296 (33.3%) were excluded because they did not present for follow-up in the clinic 3 months after discharge, 43 (4.8%) were excluded because they were admitted to a non-neurology/neurosurgery service, 7 (0.8%) were excluded for admission at < 18 years of age, 15 (1.7%) were excluded for having not had a 25-hydroxy vitamin D level measured within 24 hours of admission, and 30 (3.4%) were excluded for readmission during the same hospitalization. Patients who died before their 3-month follow-up visit were included with a GOS score of 1.
Of the patients who met the inclusion criteria, 182 (36.6%) were vitamin D deficient at the time of hospitalization. In univariate analysis, vitamin D-deficient patients were younger (mean age 49.5 ± 16.4 vs 58.0 ± 17.9 years; p < 0.001) ( Table 1) , were more likely to actively use tobacco (22% vs 13%; p = 0.009), were less likely to be taking preadmission vitamin D supplementation (7.1% vs 31.1%; p < 0.001), and had a higher BMI (29.2 ± 7.0 vs 27.9 ± 6.1 kg/m 2 ; p = 0.035). Vitamin D-deficient patients were also less likely to have a high calcium level (10.4% vs 17.8%; p = 0.028), more likely to be on Medicaid or be a self-payer (26.4% vs 11.7%; p < 0.001), and less likely to be Caucasian (79.1% vs 88.3%; p = 0.030). Vitamin Dsufficient patients were significantly less likely to require readmission within 30 days of hospital discharge (9.5% vs 13.7%; p = 0.014). At the 3-month follow-up visit, vitamin D-deficient patients were significantly more likely to have a lower GOS score (1-3) than vitamin D-sufficient patients (34.6% vs 25.1%; p = 0.023).
Fifty-nine patients (11.9%) in our cohort met criteria for severe vitamin D deficiency. In our univariate analysis, severely deficient patients were significantly younger (mean age 48.9 ± 15.2 vs 55.7 ± 18.0 years; p = 0.006) ( Table 2) , were more likely to actively use tobacco (39% vs 13.2%; p < 0.001), were less likely to be taking preadmission vitamin D supplementation (3.4% vs 24.9%; p < 0.001), and had a higher BMI (30.8 ± 9.4 vs 28.1 ± 6.0 kg/m 2 ; p = 0.002). Severely deficient patients were more likely to be on Medicaid or be a self-payer (28.8% vs 15.5%; p = 0.002) and less likely to be Caucasian (74.6% vs 86.3%; p = 0.004). Severely vitamin D-deficient patients had a higher rate of pneumonia during their hospitalization than those who were not severely deficient (13.6% vs 5.0%; p = 0.010).
At the 3-month follow-up visit, 142 patients (28.6%) had a low GOS score (1, 2, or 3), whereas 355 (71.4%) had a high GOS score (4 or 5). In univariate analysis, patients with a low GOS score were more likely to be older (mean age 60.9 ± 17.3 vs 52.5 ± 17.5 years; p < 0.001) (Table 3) ; p = 0.027). Those with a low GOS score were significantly less likely to have a high phosphate level (38.7% vs 56.6%; p < 0.001) and more likely to be deficient in vitamin D (44.4% vs 33.5%; p = 0.023) than those with a higher 3-month GOS score. The group of those who were admitted to the NCCU postoperatively had a significantly higher rate of high GOS score at the 3-month follow-up visit (44.5% vs 14.1%; p < 0.001), as did patients with private insurance (55.5% vs 36.6%; p < 0.001) and Caucasian patients (86.8% vs 80.3%; p = 0.045). Patients with a low GOS score at the 3-month follow-up visit were more likely to have stayed longer in the NCCU (5.3 ± 6.5 vs 3.2 ± 4.1 days; p < 0.001) and in the hospital overall (9.1 ± 10.5 vs 5.7 ± 5.5 days; p < 0.001), were more likely to have had a prolonged ventilator-dependent period (2.9 ± 6.6 vs 0.7 ± 3.2 days; p < 0.001), and to have developed a urinary tract infection (12% vs 5.1%; p = 0.007) or pneumonia (13.4% vs 3.1%; p < 0.001) during their stay.
Our multivariable model for GOS scores showed that SAPS II, admission category, and vitamin D status remained significantly associated with the 3-month GOS score after we adjusted for other factors (Table 4) 
Discussion
To our knowledge, we present here the first study to examine the role of vitamin D in postdischarge outcomes in the general neurocritical care population. Our data suggest that patients admitted to our NCCU without vitamin D deficiency were more than 1.7 times more likely to achieve a GOS score of 4 or 5 (moderate or low disability) than those who were deficient in vitamin D.
Increasing evidence has suggested that vitamin D plays an important role in an array of physiological functions, mediated by a widely distributed nuclear receptor implicated in hundreds of diverse metabolic pathways.
5 Vitamin D deficiency is common; the overall prevalence was greater than 40% in 1 recent pooled analysis of multiple European studies 4 and can be seen in 20%-56% of critically ill patients. 29 It has been shown to be associated with a number of negative outcomes, including increased risk of death 17 and higher rates of infection. 7 Yet there has been a lack of studies investigating the effects of hypovitaminosis D in the neurocritical care population, and to date, no data regarding posthospitalization outcomes in this group have been published. The role that vitamin D plays in the CNS continues to be an area of active investigation. Studies have found that vitamin D receptors are distributed widely in the brain, including the temporal cortex, the thalamus, and the pituitary gland. 6 These receptors might play a crucial role in a variety of processes, and vitamin D levels have been shown to influence a number of pathways in animal models ranging from the expression of nerve growth factor to the turnover rate of dopamine.
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In a 2014 study, Amrein et al.
2 investigated the effect of vitamin D supplementation on hospital lengths of stay in a randomized controlled trial among critically ill patients. Although no significant benefit with regard to length of stay was found in the supplemented group, a subgroup analysis revealed an improved in-hospital mortality rate for severely deficient subjects (≤ 12 ng/ml). Our results, combined with the lack of significant adverse events caused by supplementation found in the study by Amrein et al., 2 suggest that additional well-designed trials into the benefits of vitamin D supplementation, specifically on postdischarge outcomes in neurocritical care patients, are warranted. We are beginning a randomized clinical trial to evaluate the role of vitamin D supplementation in patients under neurocritical care.
Several limitations exist with our study. The first limitation is that the data were obtained at a single institution, which might limit the data's generalizability; the majority of our patients are Caucasian, and all of them were managed at a quaternary care center. Although our study represents one of the largest to have examined hypovitaminosis D in critically ill patients, it remains possible that it was underpowered to detect more subtle differences between groups. This might be the reason that no difference in 3-month GOS scores was found when the severely deficient subgroup was analyzed, because < 12% of our cohort was in this category. In addition, our study enrolled a heterogeneous cohort of patients with a variety of neurological and neurosurgical conditions. We attempted to control for this heterogeneity in several ways. Although the number of patients was not large enough to allow for robust analysis of individual pathologies, the division of patients into broad diagnostic categories and the inclusion of these categories in our regression analysis possibly mitigated a degree of confounding. The use of the SAPS II in our regression model also enabled us to control for the level of illness of patients in the comparison groups. Although the SAPS II was developed initially as a predictive tool for in-hospital death, multiple studies have demonstrated its utility in predicting longer-term outcomes in critically ill patients. 9, 22, 24 Despite these safeguards, it is possible that other confounders that could skew our results exist. Future studies examining more targeted subgroups of patients under neurocritical care is needed to determine whether certain conditions are affected by hypovitaminosis D more than others are.
The fact that one-third of the patients could not be evaluated for GOS score at the 3-month follow-up visit also represents a major limitation of our analysis, although average vitamin D levels between those included in the study and those who were excluded were not significantly different (26.3 ± 12.9 [included patients] vs 25.5 ± 13.1 [exclud- Despite these results, the possibility exists that the absence of available 3-month GOS scores for such a high proportion of our patients had a significant effect on our findings. Providing supplementation for our patients who were found to be deficient in vitamin D might have introduced further confounding into our study, although we would expect that attempts to normalize hypovitaminosis D would tend to bias us more toward the null hypothesis.
We also did not collect vitamin D levels of our patients at follow-up, and future studies would certainly benefit from evaluations of vitamin D level after discharge. Last, the fact that GOS scores were assessed without blinding to vitamin D levels might have biased our results.
Conclusions
Vitamin D deficiency on admission is associated with a worse 3-month outcome as measured by GOS scores in patients who presented to our NCCU. Because of the design of our study, it is impossible to infer any form of causation in regard to our findings. Although it is possible that such a relationship exists between vitamin D level and 3-month outcome in the neurocritical care population, a well-designed randomized controlled trial to investigate the use of vitamin D supplementation in this subpopulation of critically ill patients is needed before such a determination can be made, and performing such a study should be the next step taken. 
